1-9 of 9
Evangelos Terpos
Close
Sort by
Journal Articles

Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma

Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Ilvy Schweitzer, Noopur Raje, Philippe Moreau, Ajay K. Nooka
Journal: Blood Advances
Blood Adv bloodadvances.2024013461.
https://doi.org/10.1182/bloodadvances.2024013461
Published: 2024
Includes: Supplemental data
Journal Articles

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Cirino Botta, Catarina Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, María-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo Roccaro, Hartmut Goldschmidt, Hervé Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel, Bruno Paiva,
Journal: Blood Advances
Blood Adv (2022) 6 (2): 690–703.
https://doi.org/10.1182/bloodadvances.2021005198
Published: 2022
Includes: Supplemental data
Journal Articles

Determination of MYD88 L265P mutation fraction in IgM monoclonal gammopathies

Tina Bagratuni, Athina Markou, Dimitrios Patseas, Nefeli Mavrianou-Koutsoukou, Foteini Aktypi, Christine Ivy Liacos, Aimilia D. Sklirou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioannis P. Trougakos, Evi Lianidou, Evangelos Terpos, Efstathios Kastritis, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2022) 6 (1): 189–199.
https://doi.org/10.1182/bloodadvances.2021005354
Published: 2022
Includes: Supplemental data
Journal Articles

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study

Clinical Trials & Observations
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4398–4405.
https://doi.org/10.1182/bloodadvances.2021005444
Published: 2021
Journal Articles

Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study

Clinical Trials & Observations
Evangelos Terpos, Noopur Raje, Peter Croucher, Ramon Garcia-Sanz, Xavier Leleu, Waltraud Pasteiner, Yang Wang, Anthony Glennane, Jude Canon, Charlotte Pawlyn
Journal: Blood Advances
Blood Adv (2021) 5 (3): 725–736.
https://doi.org/10.1182/bloodadvances.2020002378
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone

Clinical Trials & Observations
Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios C. Ziogas, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Ioanna Dialoupi, Stavroula Giannouli, Panagiotis Tsirigotis, Sossana Delimpasi, Despina Mparmparousi, Mairylin Spyropoulou-Vlachou, Aikaterini Xirokosta, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4095–4103.
https://doi.org/10.1182/bloodadvances.2019000539
Published: 2019
Journal Articles

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3002–3009.
https://doi.org/10.1182/bloodadvances.2019000147
Published: 2019
Includes: Supplemental data
Journal Articles

Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial

Clinical Trials & Observations
Ersi Voskaridou, Ioannis Ntanasis-Stathopoulos, Athanasios Papaefstathiou, Dimitrios Christoulas, Maria Dimopoulou, Konstantina Repa, Athanasios Papatheodorou, Melpomeni Peppa, Evangelos Terpos
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2837–2847.
https://doi.org/10.1182/bloodadvances.2018023085
Published: 2018
Includes: Supplemental data
Journal Articles

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis
Journal: Blood Advances
Blood Adv (2017) 1 (7): 449–454.
https://doi.org/10.1182/bloodadvances.2016003269
Published: 2017